• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News  
Title Created Date
Low-grade Non-Hodgkin Lymphoma at advanced stage: case report 17 November 2013
High-grade non-Hodgkin's lymphoma: case report 17 October 2013
Neuroblastoma: Complete objective response to biological treatment 28 July 2013
Oesophageal squamocellular carcinoma: a complete and objective response 09 July 2013
Advanced Lung Adenocarcinoma and Low Performance Status: study on 23 patients 26 June 2013
Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission 02 June 2013
Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients 22 May 2013
Complete objective response to biological therapy of plurifocal breast carcinoma 06 May 2013
Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer 27 March 2013
Di Bella Method's improved survival, objective response and performance status in a retrospective observational clinical study on 55 cases of Lymphomas 10 February 2013
Display # 

Page 2 of 3

  • Start
  • Prev
  • 1
  • 2
  • 3
  • Next
  • End

Search

Follow us...

Latest

  • Gene expression profiling to identify oncogenic determinants of autocrine human growth hormone in human mammary carcinoma
  • Autocrine human growth hormone stimulates the tumor initiating capacity and metastasis of estrogen receptor-negative mammary carcinoma cells
  • Expression of GHRH-R, a Potentially Targetable Biomarker, in Triple-negative Breast Cancer
  • Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma
  • Assessing the diagnostic, prognostic, and therapeutic potential of the somatostatin/cortistatin system in glioblastoma
  • Vitamin A and Retinoids in Bladder Cancer Chemoprevention and Treatment: A Narrative Review of Current Evidence, Challenges and Future Prospects
  • Vitamin C as a Modulator of the Response to Cancer Therapy
  • An update on vitamin D signaling and cancer
  • AlphaCP1 mediates stabilization of hTERT mRNA by autocrine human growth hormone
  • All-Trans Retinoic Acid Inhibits Human Colorectal Cancer Cells RKO Migration via Downregulating Myosin Light Chain Kinase Expression through MAPK Signaling Pathway
  • Dynamic properties of the growth hormone releasing hormone receptor (GHRHR) and molecular determinants of GHRH binding
  • Combination Treatment of Retinoic Acid Plus Focal Adhesion Kinase Inhibitor Prevents Tumor Growth and Breast Cancer Cell Metastasis
  • Melatonin Reduces Angiogenesis in Serous Papillary Ovarian Carcinoma of Ethanol-Preferring Rats
  • About melatonin - 1996
  • Inhibition of autophagy triggers melatonin-induced apoptosis in glioblastoma cells
  • Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
  • Vitamin D Supplementation During Neoadjuvant Chemotherapy for Breast Cancer Improves Pathological Complete Response: A Prospective Randomized Clinical Trial
  • Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study

Most Read

  • The Di Bella Method (DBM)
  • All-trans-retinoic acid and cancer
  • About melatonin - 1996
  • Biography
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • Bibliography
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • How effective is chemo therapy?
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Vademecum
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Di Bella Method's improved survival, objective response and performance status in a retrospective observational clinical study on 55 cases of Lymphomas
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients